Celldex Therapeutics, Inc. (CLDX) was a big mover last session, as its shares rose over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally reverses the recent downtrend for the company, as the stock is now down roughly 43% in the past one-month time frame.
Over the last 30 days, the company witnessed a mixed track record of five positive and three negative estimate revisions while the Zacks Consensus Estimate moved lower signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday’s move higher lasts.